Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
@ LB28
You can't make a test that's better than 100%. To be clear, NCYT/Primerdesign's 41,000+ sequencing testing is actually over millions of tests worldwide.
@ solstace
Genesig tests come in many shipping formats for all regions in the world. Anything from -20 to +40 degrees. They can be stocked for extended periods and are robust. The webinar last week went into that in great detail. Quite brilliant actually.
@ saint
Please go back and re-read the thread. Solstace came to NCYT's board today and was spamming it with mis-information. I checked here to see if he had done the same thing and here he was. As I said I was just here to clear up the RNS as he had misinterpreted that.
You can check my post history, I never post in other boards aside from when I'm either trading or investing in them. But yes I will keep responding if I'm replied to as a courtesy.
Primer Design just put out their latest sequencing report:
https://twitter.com/PrimerdesignLtd/status/1287669048700997633?s=20
Still 100% after over 41,000 sequences. Meaning it's still detecting any small mutation in any setting.
No way they're moving to selling anything worse than this. That 2 gene test is just for the French so they can get refunds from insurers. When/if the insurers update their policy I wouldn't be surprised if NCYT pulls that test from the market again, it's a worse test.
Look, good luck guys. Hope you can maybe get something to market and well public health body contracts are now out of the question for you, but maybe there's some private stuff you can find. Just there's so many tests coming to market, literally 100s. But you're bound to get some test orders here and there.
I'll keep popping in once in a while to keep solstace in check of course and let you know how our sales contracts from our new lineup is going:
Saliva testiing
Rapid 100% PCR testing
Care home adoption
Airport adoption
Winter test kits
Antibody kits
@ LB28
Gold standard comes with the 100% specificity and sensitivity and WHO approval. Look:
https://twitter.com/PrimerdesignLtd/status/1287669048700997633?s=20
Over 41,000 sequences run and 100% detection. That's insane. That means it's detected every single little mutation yet.
So before there was the issue where PCR lab tests took 5 hours and so there was a rush for rapid tests and labs didn't know how to do it. So they went back to trying less specific and sensitive test types. The argument then became about accurate v fast testing.
That's now a false dichotomy. NCYT now does rapid 1 hour 100% testing and can even pick it up from low viral loads in saliva. Now some test that might miss a mutation, but the gold standard original design. And you don't even need to train technicians now for the saliva prep. It's automated, simple and super fast.
And being trialed in community settings as we speak. It's now about 100% rapid testing. Anything else can go and compete for a few contracts when/if they launch and get approval later in the year.
Exactly solstace! You said earlier it was 'nothing to do with France'.
And now you're linking a website explaining exactly what I just explained to you.
This was a French insurance reimbursement issue. Novacyt was selling a brand new type of test that can detect mutations and has detected every mutation yet, it's really brilliant. I will link you to the latest specificity report shortly.
In France you can buy tests (both private and public agencies) and then later claim the money back from the insurer. Now the insurer only knows of the old fashioned style two gene test and hasn't updated its policy for NCYT's new test.
Technically then you couldn't claim money back for that test!
French market was really disappointed so NCYT has now ran up a quick test for the French markets - public and private.
That's all. NCYT will continue to sell the single gene test primarily as it's far better - it can always detect mutations. That's why it was developed in the first place and why the WHO and FDA jumped on it.
The RNS says the single gene test is better as it will always detect mutations and the US FDA and WHO approved it for that reason.
France has a reimbursement issue as it didn't even know NCYT's test existed, until they update the insurance policy you can only get a refund in France for a regular older style PCR test.
You're reading the RNS but you don't understand what has happened so you're a bit confused or intentionally spreading misinformation.
It's been explained to you a number of times but you keep posting the RNS test for some odd reason.
Can you list the countries which NCYT's WHO approved single gene test wasn't good enough for?
I can't think of a single country it isn't approved for.
Can you name even one?
I noticed solstice posting some nonsense in the NCYT forum today so popped over to see if he was trying to spread misinformation here too and yep, here he is. I'll have to stick around here and keep an eye on that.
He's misinterpreting a situation between NCYT's test and insurance reimbursement in France. NCYT's test is sold and approved in France and all over the world as it is best in class, 100% spec and sensitivity over millions of tests (see the latest report on PrimerDesign's feed). Now the traditional PCR test uses something called gene amplification and basically any regular PCR test can be reimbursed if it used this method (because it's accurate and proven).
Now when PrimerDesign wanted to bring out a test early at the start of the crisis, they saw two existing methods already on the market, and saw issues with both off them. They put a brief to their R&D team to create a new test that would not have any of the issues that saw with existing methods. After testing it was an NHS trust locally, they then went on to test it with PHE whoo then put to the world health organisation.
There's some misinformation being spread by solstace on the NCYT forum today as if NCYT's test was dated or not fit for purpose. The issue with the test was that it was ahead of the curve, not behind it. France's insurance body is lagging behind a fast moving testing market. To help French national bodies get reimbursed NCYT quickly developed a two gene test, which was easy for them to do. These are petty common. It's just a way to get more funds out of the French public testing market.
The gold standard test is still their original one developed earlier in the year, which has now got a saliva version which can detect even low viral loads. And a rapid test version that's fully automated with results in an hour. We will see NHS trusts and care homes adopt these come September (they're trialing it at the moment in that setting). The rapid PCR test will now be rolled out to other settings, and we suspect airports is the next big adopter (see: Collinson's Heathrow trial).
Winter test kit as the NHS has asked for and other public bodies worried about the second wave while dealing with influenza too.
That was the gist of the RNS, not what solstace was trying to suggest on the NCYT forum. I'll keep an eye out here and post more regularly if I see he keeps up this mis0information campaign and try too clear things up.
Market didn't even know these new products were coming so the share price hasn't baked in the sales for those. We will get sales updates soon. Still waiting on a bunch of old updates, US etc.
Re-rate comes when we get the numbers.
Unboxing video of a q16 to get an idea of how small this thing is:
https://youtu.be/_0Ci9wepmTo?t=63
@ wood
Yes the pilot, but a full roll out would happen only with government approvals (which is what they're looking for with the pilot).
The whole setup will have to be govt. funded. Either way is good, but I can't see airlines being successful if govt's won't pay for testing. You'll sink the carriers that rely on cheap flights.
@ wood
Testing in the UK will be free for sure. It's already funded by the government. France too reimburses testing costs. If you need to stimulate the travel and tourism industry, you can't make travel more expensive when people are less likely to want to travel. On top of the inconvenience too.
I just can't see it.
Germany announced free airport testing:
https://www.dw.com/en/german-airports-will-offer-free-covid-19-tests-to-returning-holidaymakers/a-54310388
Emirates doing free testing
Heathrow doing the trial with Collinson, we know UK testing is free.
I'm sure if you run a Google search you'll keep seeing free airport testing or free government testing news come up.
@ Captain
The cost to governments to subsidise testing etc compared to the economic hit is tiny. Airport testing has to be standardised else it becomes confusing to consumers. It has to be the best test and has to be at least supervised by a technician to have any chance of approval by countries like China (they already only allow a few select labs in each country to perform a PCT antigen test that they'll accept). I can't see individual airlines being allowed to pick and choose testing.
Governments will pay for all this and PCT companies will make tests faster and cheaper as the next 12 to 24 months roll on.
Even if the virus gets smashed next year, they still need to maintain testing for the foreseeable future years ahead to know it's not returning. Homeland's analysts have a 5 year projection and PCT is over 22 billion and that's the low end projection.
Shaun P does excellent work here, but after today he's got his work cut out for him. Too many new products and not indications on costs and margins. Might have to base models on similar products.
Winter test kit sales will be solid to northern hemisphere countries public health bodies. NHS has been saying they're worried about flu season and aren't prepared. Bet this kit was developed with an NHS trust, just like the mobile test was.
@ Captain
Collinson disagrees. They're implementing PCR as the chosen method to get airports around the world moving again. They're doing that because they need to most accurate test, administered by a technician to get world-wide govt's approvals. There can be no compromise. NCYT's sub 1 hour PCR test is also 100% and must faster than even Collinson first through possible. That news is coming soon.
See here:
https://www.collinsongroup.com/en-eur/insights/collinson-and-swissport-ready-to-pilot-airport-based-covid-19-testing
"The tests use the gold standard of virus detection, RT-PCR testing. They are sensitive enough to detect the particles of COVID-19, even if the passenger has displayed no symptoms."
Quick release from quarantine if you pass.
Also think it's either Astra or Yourgene for antibody tests. Existing partnerships for both, but who knows, a lot has happened behind closed doors clearly. Caught us all out!
@ noodle
Yes that NCYT will be supplying the NHS Trusts and existing partners with theirs. Looking forward to hearing about NCYT's US sales now too.
Have fun buying back those shares boys
https://bdif.amf-france.org/en_US/Resultat-de-recherche-BDIF?formId=BDIF&DOC_TYPE=BDIF&LANGUAGE=en&subFormId=dpcn&BDIF_TYPE_INFORMATION=BDIF_TYPE_INFORMATION_DPCN&TEXT=&BDIF_RAISON_SOCIALE=NOVACYT&bdifJetonSociete=RS00005391&REFERENCE=&DATE_PUBLICATION=&DATE_OBSOLESCENCE=&valid_form=Start+search&isSearch=true
Jesus!
Not way anyone expected even half of that stuff in a single RNS. We didn't even truly believe that some of that stuff was in development. That's all the things!
Constant sales updates for all these new products and areas is going to be insane. Even sorted out the nonsense with the French market. Antibody testing, saliva, it's everything!